Research team breakthrough in delivering drugs to the brain

March 11, 2013
UCL research team breakthrough in delivering drugs to the brain

Researchers at UCL have made a breakthrough in the way that drugs could be delivered to the brain.

Ijeoma F. Uchegbu, Mariarosa Mazza, Andreas G. Schätzlein and their colleagues have tackled the difficult problem of constructing drugs which are able to pass through the blood-brain barrier – a mechanism which prevents many chemicals in the bloodstream from passing into the brain, including administered as medication as well as harmful .

A new class of drugs – peptide drugs – are now at the forefront of tackling this problem, which, if solved, could revolutionise delivery of pain relief as well as offer hope in treating such as Alzheimer's and Parkinson's diseases. Enabling such drugs to cross the blood-brain barrier is key to revolutionising the treatment of these conditions.

Professor Uchegbu and her team's breakthrough has been to modify a pain-relief drug – Dalargin – to successfully cross this barrier through attaching a group of lipids, or fat molecules, to enable its passage into the brain in mice in the form of a molecule known as a nanofibre.

To see if the helped the drug reach the brain, the team at UCL injected two groups of mice with the drug: one were given the unmodified version, while the other were administered the drug in the form of a nanofibre. After scanning, it was found that the modified drug has successfully passed into the brains of the mice that had ingested it.

"This is really just the tip of the iceberg in the potential of this type of structure in terms of how we can deliver drugs to the brain," says Professor Uchegbu. "It could be expanded to a whole range of other peptide drugs, and we are looking in the future to focus on whether we can transfer the success of this research to other classes of drugs, such as enkephalins.

Explore further: Toward the first nose drops to treat brain cancer

Related Stories

Toward the first nose drops to treat brain cancer

September 22, 2010

Scientists are reporting the development and successful initial testing of a new form of methotrexate -- the mainstay anticancer drug -- designed to be given as nose drops rather than injected. It shows promise as a more ...

New method delivers Alzheimer's drug to the brain

March 21, 2011

(PhysOrg.com) -- Oxford University scientists have developed a new method for delivering complex drugs directly to the brain, a necessary step for treating diseases like Alzheimer’s, Parkinson’s, Motor Neuron Disease ...

Recommended for you

Basic research fuels advanced discovery

August 26, 2016

Clinical trials and translational medicine have certainly given people hope and rapid pathways to cures for some of mankind's most troublesome diseases, but now is not the time to overlook the power of basic research, says ...

New avenue for understanding cause of common diseases

August 25, 2016

A ground-breaking Auckland study could lead to discoveries about many common diseases such as diabetes, cancer and dementia. The new finding could also illuminate the broader role of the enigmatic mitochondria in human development.

New method creates endless supply of kidney precursor cells

August 25, 2016

Salk Institute scientists have discovered the holy grail of endless youthfulness—at least when it comes to one type of human kidney precursor cell. Previous attempts to maintain cultures of the so-called nephron progenitor ...

Strict diet combats rare progeria aging disorders

August 25, 2016

Mice with a severe aging disease live three times longer if they eat thirty percent less. Moreover, they age much healthier than mice that eat as much as they want. These are findings of a joint study being published today ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.